Competitor Analysis: G-CSF & GM-CSF

Date: January 22, 2011
Pages: 40
Price:
US$ 454.00
License [?]:
Publisher: La Merie Publishing
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: C0B4F18092AEN
Leaflet:

Download PDF Leaflet

Competitor Analysis: G-CSF & GM-CSF
The present Competitive Intelligence Report about G-CSF & GM-CSF products in the pipeline and off-patent products provides a competitor evaluation in the field of G-CSF & GM-CSF branded products in regulated markets and products in non-regulated markets, biosimilars (biogenerics, follow-on biologics) and next generation, longer acting products or new uses of G-CSF as of January 2011. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report includes a compilation of currently marketed branded and non-branded G-CSF and GM-CSF products in regulated and non-regulated markets for treatment of chemotherapy-induced neutropenia. The report includes the market size of branded G-CSF products in 2009. It lists the most advanced biosimilars of G-CSF and pegylated G-CSF and of GM-CSF. It describes the companies with G-CSF and GM-CSF products and of pegylated versions in non-regulated markets. In addition, the report lists company-specific R&D pipelines of G-CSF/GM-CSF products and projects. Competitor projects are listed in a tabular format providing Information on:
  • Drug Codes,
  • Target / Mechanism of Action,
  • Class of Compound,
  • Company,
  • Territory,
  • Indication,
  • R&D Stage and
  • additional comments with a hyperlink leading to the source of information.

Index
  • 1st Generation branded G-CSF products in regulated markets
  • Biosimilar 1st generation G-CSF products in regulated markets
  • Next generation G-CSF products and uses in regulated markets
  • Biosimilar next generation G-CSF products and uses in regulated markets
  • 1st generation G-CSF products in non-regulated markets
  • Next generation G-CSF products in non-regulated markets
  • 1st and next generation GM-CSF products in regulated markets
  • 1st and next generation GM-CSF products in non-regulated markets
  • About La Merie

About Competitor Analysis Series:

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.
Skip to top


Ask Your Question

Competitor Analysis: G-CSF & GM-CSF
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: